Camp4 Therapeutics (CAMP) Income from Continuing Operations (2023 - 2025)
Historic Income from Continuing Operations for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$13.2 million.
- Camp4 Therapeutics' Income from Continuing Operations rose 189.85% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.6 million, marking a year-over-year decrease of 40.67%. This contributed to the annual value of -$51.8 million for FY2024, which is 507.19% down from last year.
- Per Camp4 Therapeutics' latest filing, its Income from Continuing Operations stood at -$13.2 million for Q3 2025, which was up 189.85% from -$12.6 million recorded in Q2 2025.
- In the past 5 years, Camp4 Therapeutics' Income from Continuing Operations registered a high of -$11.7 million during Q3 2023, and its lowest value of -$13.5 million during Q3 2024.
- Its 3-year average for Income from Continuing Operations is -$12.7 million, with a median of -$12.6 million in 2025.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 1528.73% in 2024, then surged by 189.85% in 2025.
- Quarter analysis of 3 years shows Camp4 Therapeutics' Income from Continuing Operations stood at -$13.0 million in 2023, then fell by 2.22% to -$13.3 million in 2024, then increased by 0.38% to -$13.2 million in 2025.
- Its Income from Continuing Operations stands at -$13.2 million for Q3 2025, versus -$12.6 million for Q2 2025 and -$12.5 million for Q1 2025.